Oncology
7 drugs are in development for Chronic Lymphocytic Leukemia.
- Companies
- 3
- Clinical trials
- 91
Prepared research question
Which programs lead the Chronic Lymphocytic Leukemia pipeline—and what evidence could change the picture?
Traceable citations · Unknowns marked
Drug Pipeline by Phase
| Drug | Company |
|---|---|
| viibryd | AbbVie Inc. (ABBV) |
| Drug | Company |
|---|---|
| PRGN-3005 | PRECIGEN, INC. (PGEN) |
| PRGN-3006 | PRECIGEN, INC. (PGEN) |
| PRGN-3007 | PRECIGEN, INC. (PGEN) |
| sc291 | Sana Biotechnology, Inc. (SANA) |
About this indication
Chronic Lymphocytic Leukemia context
Also known as: B Cell Chronic Lymphocytic Leukemia, B Cell Leukemia, Chronic, B Cell Malignancy, Low Grade, B Lymphocytic Leukemia, Chronic, B-Cell Leukemias, Chronic, B-Cell Malignancies, Low-Grade, B-Lymphocytic Leukemias, Chronic, CLL Lymphoplasmacytoid Lymphoma, CLL Lymphoplasmacytoid Lymphomas, Chronic Lymphatic Leukemia, Chronic Lymphatic Leukemias, Chronic Lymphoblastic Leukemia, Chronic Lymphoblastic Leukemias, Chronic Lymphocytic Leukemias, Diffuse Well Differentiated Lymphocytic Lymphoma, Disrupted In B Cell Malignancy, Leukemia, B Cell, Chronic, Leukemia, Chronic Lymphocytic, B-Cell, Leukemia, Lymphoblastic, Chronic, Leukemia, Lymphocytic, Chronic, Leukemia, Lymphocytic, Chronic, B Cell, Lymphocytic Leukemia, Chronic, B Cell, Lymphocytic Lymphoma, Lymphocytic Lymphoma, Diffuse, Well Differentiated, Lymphocytic Lymphoma, Small, Lymphocytic Lymphomas, Lymphocytic Lymphomas, Small, Lymphocytic Lymphomas, Well-Differentiated, Lymphoma, Lymphocytic, Diffuse, Well Differentiated, Lymphoma, Lymphocytic, Well Differentiated, Lymphoma, Lymphoplasmacytoid, CLL, Lymphoma, Small Lymphocytic, Plasmacytoid, Lymphoma, Well-Differentiated Lymphocytic, Lymphomas, Small-Cell, Small Cell Lymphoma
Prevalence
20.0 / 100K
Incidence
4.7 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Chronic Lymphocytic Leukemia?
BioSniper tracks 7 drugs in development for Chronic Lymphocytic Leukemia across 3 companies.
How many clinical trials target Chronic Lymphocytic Leukemia?
There are 91 clinical trials targeting Chronic Lymphocytic Leukemia tracked by BioSniper.
What is the prevalence of Chronic Lymphocytic Leukemia?
The estimated prevalence of Chronic Lymphocytic Leukemia is approximately 20.0 per 100,000 population.